6 posts categorised "Pharmaceuticals & life sciences"

September 10, 2019 What does Brexit mean for your working capital? We analyse the UK’s performance on working capital in the run-up to Brexit, where abnormal cash-flow patterns will require close attention.

November 29, 2016 PwC Deals Index* – M&A Year to Q3 2016 By James Fillingham Follow @JSJFillingham The result of the referendum had limited impact on UK deal activity in Q3 ’16, which remained in line with...

August 18, 2016 Deals Index* – Q216 Update: The UK M&A market post the EU Referendum result By James Fillingham The impact of the result of the referendum on deals is still being debated hotly and, while there are many viewpoints, there...

September 07, 2015 Deals Index* – a look over H1 2015 and outlook for H2 2015 By James Fillingham From a global perspective, so far in 2015, the deal market has continued to be strong in value terms. According to Mergermarket...

June 23, 2015 Webinar: Why are early stage assets becoming more popular? By Romil Radia and Katrina Hallpike With increasingly buoyant public markets in the UK, we are seeing increased interest and deal activity for early stage...

May 15, 2014 Global pharma: Shape up or ship out… By Akshawra Guru With over $189bn worth of transaction activity making headlines in little over two weeks, the shifting dynamics of the pharmaceutical industry are...

Popular categories

Follow PwC